Objectives : Bower Actinidia has been widely used for treatment of inflammatory diseases, such as jaundice, cystolithiasis. However, the mechanism of its anti-inflammatory activity has not been clarified. In this study, we investigated the inhibitory effect of Bower Actinidia pharmacopuncture extract(BA) on LPS-induced inflammation. Methods : The effect of BA was analyzed by ELISA, RT-PCR and Western blotting in LPS-stimulated RAW264.7 cells. Results : We found that BA suppressed not only the mRNA expression of pre-inflammatory cytokines, cyclooxygenase-2(COX-2) and inducible nitric oxide synthase(iNOS), but also the phosphorylation of ERK, JNK and p38. Conclusions : These results suggest that BA exerts an anti-inflammatory effect through the regulation of the mitogen-activated protein kinase(MAPK) pathway, thereby decreasing production of pre-inflammatory cytokines.
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Expression of these genes was assayed by RT-PCR. GAPDH was used as internal control genes. (Fig. 2C ). (Fig. 3A) .
전구 염증 매개 cytokine 유전자 발현에 미치는 영향
PGE2 생산과 COX-2 유전자 및 단백질 발현에 미치 는 영향
COX-2 mRNA의 발현량은 대조군에서 거의 발현되지 않았으나
LPS 자극군에서 현저하게 증가하였으며, BA(1, 2 및 4 mg/ml) 전처 리한 세포에서 유전자의 발현이 감소하는 것으로 나타났다 (Fig. 3B ).
COX-2 단백질의 발현량은 대조군에서 약하게 발현되었으나
LPS 자극군에서 현저하게 증가하였으며, BA(1, 2 및 4 mg/ml) 전 처리한 세포에서 단백질의 발현이 점차 감소하는 것으로 나타났다 (Fig. 3C ). 
NO 생산과 iNOS 유전자 및 단백질 발현에 미치는 영향
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